SE420728B - Sett att framstella piperazinyliminorifamyciner - Google Patents

Sett att framstella piperazinyliminorifamyciner

Info

Publication number
SE420728B
SE420728B SE7602122A SE7602122A SE420728B SE 420728 B SE420728 B SE 420728B SE 7602122 A SE7602122 A SE 7602122A SE 7602122 A SE7602122 A SE 7602122A SE 420728 B SE420728 B SE 420728B
Authority
SE
Sweden
Prior art keywords
piperazinyliminorifamycines
make
make piperazinyliminorifamycines
Prior art date
Application number
SE7602122A
Other languages
English (en)
Swedish (sv)
Other versions
SE7602122L (sv
Inventor
R Chricchio
V Arioli
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE7602122L publication Critical patent/SE7602122L/xx
Publication of SE420728B publication Critical patent/SE420728B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7602122A 1975-03-05 1976-02-23 Sett att framstella piperazinyliminorifamyciner SE420728B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10020/75A GB1478563A (en) 1975-03-05 1975-03-05 Rifamycin derivatives

Publications (2)

Publication Number Publication Date
SE7602122L SE7602122L (sv) 1976-09-06
SE420728B true SE420728B (sv) 1981-10-26

Family

ID=9959968

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7602122A SE420728B (sv) 1975-03-05 1976-02-23 Sett att framstella piperazinyliminorifamyciner

Country Status (27)

Country Link
US (1) US4002752A (nl)
JP (1) JPS51113900A (nl)
AR (1) AR210113A1 (nl)
AT (1) AT344896B (nl)
BE (1) BE839255A (nl)
CA (1) CA1057748A (nl)
CH (1) CH610325A5 (nl)
DD (1) DD123888A5 (nl)
DE (1) DE2608218C3 (nl)
DK (1) DK136655B (nl)
ES (1) ES445790A1 (nl)
FI (1) FI59102C (nl)
FR (1) FR2302742A1 (nl)
GB (1) GB1478563A (nl)
HK (1) HK35282A (nl)
HU (1) HU170451B (nl)
IE (1) IE42881B1 (nl)
KE (1) KE3099A (nl)
LU (1) LU74478A1 (nl)
MX (1) MX3737E (nl)
NL (1) NL165745C (nl)
NO (1) NO143796C (nl)
PT (1) PT64866B (nl)
SE (1) SE420728B (nl)
SU (1) SU575030A3 (nl)
YU (1) YU39477B (nl)
ZA (1) ZA761043B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2728869A1 (de) * 1976-06-25 1977-12-29 Antibiotice Iasi Intreprindere Rifamycinen und verfahren zu deren herstellung
GR64108B (en) * 1977-04-15 1980-01-24 Dso Pharmachim Method for the preparation of azomethine-derivatives of rifamycin s.v
GB1576886A (en) * 1977-04-20 1980-10-15 Lepetit Spa Rifamycin derivatives
GB1594134A (en) * 1977-11-25 1981-07-30 Holco Investment Inc Rifamycins
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
WO1987002361A1 (en) * 1985-10-18 1987-04-23 Ciba-Geigy Ag Substituted 4-benzyl-piperazinyl compounds
AU621811B2 (en) * 1987-09-25 1992-03-26 Ciba-Geigy Ag Diacyl derivatives of 4-(trialkylbenzyl)-piperazinyl compounds
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides
EP0536197B1 (en) * 1990-06-29 1995-07-26 GRUPPO LEPETIT S.p.A. Pure crystalline form of rifapentine
JP5368092B2 (ja) 2005-08-11 2013-12-18 ターガンタ セラピュティクス，インコーポレイティド ホスホン化リファマイシン類および骨と関節感染の予防と治療のためのその投与法
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
PT2882435T (pt) 2012-08-13 2021-06-18 Kiril Asenov Ninov Formulações farmacêuticas contendo 3-(4-cinamil-lpiperazinil)amino derivados da 3-formilrifamicina s
CN103951677B (zh) * 2014-03-17 2016-04-06 四川省长征药业股份有限公司 利福喷丁的制备方法
WO2022225384A1 (es) * 2021-04-21 2022-10-27 Interquim, S.A. De C.V. Proceso de obtención de rifapentina. con una nueva forma cristalina
CN115047122B (zh) * 2022-06-29 2023-05-02 重庆华邦胜凯制药有限公司 利福喷丁及其合成过程中所产生的杂质的分析方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (nl) * 1964-07-31
AR205434A1 (es) * 1972-03-27 1976-05-07 Lepetit Spa Proceso para la preparacion de 3-acilhidrazonometil rifamicinas sv
GB1392272A (en) * 1972-05-31 1975-04-30 Lepetit Spa 3-formylrifamycin azines

Also Published As

Publication number Publication date
IE42881B1 (en) 1980-11-05
JPS51113900A (en) 1976-10-07
DE2608218A1 (de) 1976-09-16
ZA761043B (en) 1977-01-26
NO760549L (nl) 1976-09-07
FI59102C (fi) 1981-06-10
MX3737E (es) 1981-06-05
PT64866A (en) 1976-04-01
ATA162876A (de) 1977-12-15
SU575030A3 (ru) 1977-09-30
YU39477B (en) 1984-12-31
FR2302742A1 (fr) 1976-10-01
CH610325A5 (nl) 1979-04-12
HU170451B (nl) 1977-06-28
IE42881L (en) 1976-09-05
DE2608218B2 (de) 1981-02-26
BE839255A (fr) 1976-09-06
GB1478563A (en) 1977-07-06
CA1057748A (en) 1979-07-03
NO143796B (no) 1981-01-05
DK136655C (nl) 1978-04-17
YU57276A (en) 1982-06-30
NL165745C (nl) 1981-05-15
AT344896B (de) 1978-08-10
ES445790A1 (es) 1977-06-01
NL7602191A (nl) 1976-09-07
NO143796C (no) 1981-04-15
KE3099A (en) 1981-02-13
HK35282A (en) 1982-08-13
LU74478A1 (nl) 1976-09-01
FI59102B (fi) 1981-02-27
DK136655B (da) 1977-11-07
SE7602122L (sv) 1976-09-06
NL165745B (nl) 1980-12-15
FI760561A (nl) 1976-09-06
US4002752A (en) 1977-01-11
DK78476A (nl) 1976-09-06
DE2608218C3 (de) 1981-12-10
PT64866B (en) 1977-07-20
AU1170476A (en) 1977-09-08
DD123888A5 (nl) 1977-01-19
FR2302742B1 (nl) 1979-10-12
JPS5530797B2 (nl) 1980-08-13
AR210113A1 (es) 1977-06-30

Similar Documents

Publication Publication Date Title
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE422077B (sv) Sett att framstella syntesgas
SE7606280L (sv) Sett att framstella etrar
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE7612532L (sv) Sett att framstella grundpalar
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7607078L (sv) Sett att framstella skumpolykarbamid
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE7606484L (sv) Sett att framstella hoghallfasta cementkonglomerat
SE430687B (sv) Sett att framstella hexanitrostilben
SE7708841L (sv) Sett att framstella rifamycinforeningar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE425321B (sv) Sett att reducera vanadinoxider
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7609269L (sv) Sett att framstella polymerblandningar
SE7607171L (sv) Sett att framstella indolokinoliziner
SE7603895L (sv) Sett att framstella skumplaster
SE420690B (sv) Sett att kontinuerligt framstella vermeisolerande ledningsror

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7602122-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7602122-9

Format of ref document f/p: F